🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for High-Risk Percutaneous Coronary Intervention (High-risk PCI)

Super High-pressure Balloon Versus Intravascular Lithotripsy to Prepare Severely Calcified Coronary Lesions NCT07093788NA3 sites📍 Lianyungang📍 Nanjing📍 Yixing Nanjing First Hospital, Nanjing Medical University · Tests: super high-pressure balloon, intravascular lithotripsy (IVL) Peri-treatment of SGLT-2 Inhibitor on Myocardial Infarct Size and Remodeling Index in Patients With Acute Myocardial Infarction and High Risk of Heart Failure Undergoing Percutaneous Coronary Intervention NCT04899479Phase 41 site📍 Seoul Samsung Medical Center · Tests: SGLT2 inhibitor, Control Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI NCT07149714NA1 site📍 Moscow National Medical Research Center for Cardiology, Ministry o… · Tests: iVAC 2L Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients NCT05923489NA1 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Routine Angiography Follow-up, Routine Clinical Follow-up LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients NCT06657326NA6 sites📍 Johor Bahru📍 Kuantan📍 Ipoh Biosensors Europe SA · Tests: BioFreedom™ Ultra cobalt-chromium Biolimus A9™-coated stent, BioFreedom™ stainless steel Biolimus A9™-coated stent Standby Cannulated ECMO for High-Risk Percutaneous Coronary Intervention NCT06274411NA1 site📍 Beijing Beijing Anzhen Hospital · Tests: Standby cannulated ECMO, Prophylactic ECMO Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty. NCT07582835Phase 31 site📍 Lugano Cardiocentro Ticino · Tests: Clopidogrel, Ticagrelor, Prasugrel Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy NCT04416581Phase 445 sites📍 Anyang📍 Bucheon-si📍 Busan Duk-Woo Park, MD · Tests: PPI, P-CAB 50 Drug-Coated Balloon in Anticoagulated and Bleeding Risk Patients Undergoing PCI NCT04814212NA14 sites📍 Jyväskylä📍 Rovaniemi📍 Kuopio North Karelia Central Hospital · Tests: Percutaneous coronary intervention using drug-coated balloon, Percutaneous coronary intervention using drug-eluting ste… Efficacy and Safety of a Beet-Derived Inorganic Nitrate-Based Food Product for the Prevention of Contrast-Induced Nephropathy in High-Risk Patients Undergoing Percutaneous Coronary Intervention NCT06984406NA1 site📍 Moscow National Medical Research Center for Therapy and Preventive… · Tests: Beet-Derived Inorganic Nitrate-Based Food Product Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patients After PCI (SMART-CARE) NCT07009418NA22 sites📍 Bucheon-si📍 Daegu📍 Daegu Samsung Medical Center · Tests: Coronary CT Angiography (CCTA) A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients. NCT03998319Phase 322 sites📍 Bankstown📍 Camperdown📍 Concord University of Sydney · Tests: Tenecteplase (1/3 systemic weight based dose), Sterile water for injection (WFI) Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2) NCT07025148Phase 41 site📍 Jacksonville University of Florida · Tests: Prasugrel, Clopidogrel Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary Intervention NCT04240834Phase 41 site📍 Beijing Fu Wai Hospital, Beijing, China · Tests: Aspirin, Ticagrelor Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI) NCT07296744NA25 sites📍 Loma Linda📍 Sacramento📍 Thousand Oaks Supira Medical · Tests: The Supira System, Impella ELEVATE High-Risk PCI Pivotal Study NCT07001332NA33 sites📍 Phoenix📍 Scottsdale📍 La Jolla Magenta Medical Ltd. · Tests: Elevate, Impella Reduced Antithrombotic Strategy for High Bleeding Risk Patients With Myocardial Infarction NCT05262803Phase 46 sites📍 Aalborg📍 Copenhagen📍 Hellerup Rikke Sorensen · Tests: CYP2C19*2/*3, Shorter DAPT duration Effect of High-intensity Statin With Ezetimibe COmbination theRapy Versus High-intensity sTatin Monotherapy After Percutaneous Coronary Intervention With Drug-eluting Stents; the ESCORT Trial NCT05782777NA1 site📍 Seoul Yonsei University · Tests: ezetimibe/high-intensity statin combination therapy (ezetimibe 10mg plus atoravastatin 40mg), high-intensity statin mon… Studying the Effectiveness of Early Invasive Treatment in Elderly Patients With High-risk Non-ST-segment Elevation Acute Coronary Syndrome. NCT06486233n/a1 site📍 Ho Chi Minh City Gia Dinh People Hospital Ultrathin Strut Sirolimus-eluting Stent With Bioabsorbable Polymer in Patients Receiving Chronic Oral Anticoagulation NCT06863155n/a13 sites📍 Albacete📍 Alicante📍 Badajoz Fundación EPIC · Tests: Supraflex Cruz Sirolimus-eluting Stent Interventional Left Ventricular Assist System for PCI in CHIP Patients NCT07053618NA15 sites📍 Beijing📍 Xiamen📍 Lanzhou Suzhou Hengruihongyuan Medical Technology Co. LTD · Tests: Implantation of the VADLINK Percutaneous Left Ventricular Assist Device, VA-ECMO Optimization of Percutaenous Coronary Intervention With Liberal Use of Post-dilatation NCT06558474n/a1 site📍 Eindhoven Cathreine BV · Tests: Liberal post-dilatation strategy during PCI Clinical Characteristics, Frailty, and Prognostic Predictors in Patients Aged 75 and Older With Acute Coronary Syndrome NCT07366684n/a1 site📍 Niš Clinical Center Niš · Tests: Percutaneous Coronary Intervention (PCI), Conservative Medical Therapy Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention NCT06186037Phase 41 site📍 Suwon Saint Vincent's Hospital, Korea · Tests: Combination drug group of Ezetimibe 10 mg/Rosuvastatin 5 mg, Mono drug group of Rosuvastatin 20 mg Feasibility Study of the Supira System in Patients Undergoing HRPCI With Support Beyond the PCI Procedure NCT07407816NA2 sites📍 Tbilisi📍 Tbilisi Supira Medical · Tests: Supira System Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure NCT06075433n/a1 site📍 Wŏnju Genoss Co., Ltd. Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI NCT04499859Phase 47 sites📍 Bucheon-si📍 Suwon📍 Uijeongbu-si Kiyuk Chang, MD,PhD · Tests: Ezetimibe 10mg + Rosuvastatin 5mg, Rosuvastatin 20mg Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease NCT06788275NA2 sites📍 Alicante📍 Elche Instituto de Investigación Sanitaria y Biomédica de Alicante · Tests: Aerobic exercise (MIT), Aerobic exercise (Short HIIT), Aerobic exercise (Long HIIT) A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation. NCT05984537Phase 41 site📍 Beijing Peking University First Hospital · Tests: Bivalirudin, standard heparin Thrombus Aspiration in STEMI Patients With High Thrombus Burden NCT04212494NA50 sites📍 Fuzhou📍 Foshan📍 Foshan Guangdong Provincial People's Hospital · Tests: Thrombus aspiration, PCI Alone
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy